Skip to main content
Unit of study_

EXSS3037: Exercise Pharmacology and Immunology

Semester 2 Early, 2020 [Normal day] - Cumberland, Sydney

This unit of study will introduce the student to the principles of pharmacology and immunology as well as the effect and influence of exercise on the respective fields. Students will gain an understanding of the pharmacokinetic and pharmacodynamic action of drugs in the body. Students will be able to describe the site and mechanism of action of selected drug groups, to identify the therapeutic use of the drug and its adverse effects, to examine the effect of the exercise and disease on drug action, and the effect of the drug on the exercise response. Special emphasis will be given to drugs used for therapeutic medication, for recreational purposes and for performance enhancement in sport. The nature of immunity, the immune response, pathological disorders of the immune system and its response to exercise and ageing will be examined.

Unit details and rules

Unit code EXSS3037
Academic unit Movement Sciences
Credit points 6
Prohibitions
? 
None
Prerequisites
? 
BIOS1170 and EXSS2028
Corequisites
? 
None
Assumed knowledge
? 

None

Available to study abroad and exchange students

Yes

Teaching staff

Coordinator Rhonda Orr, rhonda.orr@sydney.edu.au
Tutor(s) Maree Cassimatis, maree.cassimatis@sydney.edu.au
Type Description Weight Due Length
Final exam (Record+) Type B final exam hurdle task Final exam
Short answer and MCQ
50% Formal exam period 2 hours
Outcomes assessed: LO5 LO6 LO7 LO8 LO10 LO11 LO12 LO13 LO14 LO15 LO1 LO3 LO4
In-semester test (Open book) Type C in-semester exam hurdle task Mid semester exam
Short answer and MCQ
30% Week 07
Due date: 14 Sep 2020 at 14:00
50 minutes
Outcomes assessed: LO1 LO2 LO3 LO4 LO5 LO6 LO7 LO8 LO10 LO11 LO12 LO13
Assignment group assignment Drug information brochure
Case study and report
20% Week 09
Due date: 09 Oct 2020 at 23:00

Closing date: 09 Oct 2020
1000 words
Outcomes assessed: LO1 LO2 LO3 LO4 LO5 LO6 LO7 LO8 LO9 LO12 LO13 LO14 LO15
hurdle task = hurdle task ?
group assignment = group assignment ?
Type B final exam = Type B final exam ?
Type C in-semester exam = Type C in-semester exam ?

Assessment summary

  • Mid semester exam: The questions in this exam will be based on the content of the lectures, self-directed readings case studies and tutorials. A mark of at least 40% in this exam is required to be eligible for a pass in this unit. An understanding of the basic principles of pharmacology is required. Material covered in this examination will not be included in the final exam.
  • Drug information brochure: Students will work in pairs to produce an information poster on a selected drug. 
  • Final exam: The questions in this exam will be based on the content of the lectures, self-directed readings case studies and tutorials. A mark of at least 40% in this exam is required to be eligible for a pass in this unit. 

Detailed information for each assessment can be found on Canvas.

Assessment criteria

The University awards common result grades, set out in the Coursework Policy 2014 (Schedule 1).

As a general guide, a high distinction indicates work of an exceptional standard, a distinction a very high standard, a credit a good standard, and a pass an acceptable standard.

Result name

Mark range

Description

High distinction

85 - 100

 

Distinction

75 - 84

 

Credit

65 - 74

 

Pass

50 - 64

 

Fail

0 - 49

When you don’t meet the learning outcomes of the unit to a satisfactory standard.

For more information see sydney.edu.au/students/guide-to-grades.

For more information see guide to grades.

Late submission

In accordance with University policy, these penalties apply when written work is submitted after 11:59pm on the due date:

  • Deduction of 5% of the maximum mark for each calendar day after the due date.
  • After ten calendar days late, a mark of zero will be awarded.

Academic integrity

The Current Student website  provides information on academic integrity and the resources available to all students. The University expects students and staff to act ethically and honestly and will treat all allegations of academic integrity breaches seriously.  

We use similarity detection software to detect potential instances of plagiarism or other forms of academic integrity breach. If such matches indicate evidence of plagiarism or other forms of academic integrity breaches, your teacher is required to report your work for further investigation.

You may only use artificial intelligence and writing assistance tools in assessment tasks if you are permitted to by your unit coordinator, and if you do use them, you must also acknowledge this in your work, either in a footnote or an acknowledgement section.

Studiosity is permitted for postgraduate units unless otherwise indicated by the unit coordinator. The use of this service must be acknowledged in your submission.

Simple extensions

If you encounter a problem submitting your work on time, you may be able to apply for an extension of five calendar days through a simple extension.  The application process will be different depending on the type of assessment and extensions cannot be granted for some assessment types like exams.

Special consideration

If exceptional circumstances mean you can’t complete an assessment, you need consideration for a longer period of time, or if you have essential commitments which impact your performance in an assessment, you may be eligible for special consideration or special arrangements.

Special consideration applications will not be affected by a simple extension application.

Using AI responsibly

Co-created with students, AI in Education includes lots of helpful examples of how students use generative AI tools to support their learning. It explains how generative AI works, the different tools available and how to use them responsibly and productively.

WK Topic Learning activity Learning outcomes
Week 01 1. Principles of pharmacology; 2. Pharmacokinetics; 3. Pharmacodynamics Lecture (2 hr)  
Week 02 1. Drug action during exercise and ageing; 2. Autonomic pharmacology; 3. Cholinergic drugs Lecture (2 hr)  
Week 03 1. Sympathomimetic drugs; 2. Drugs in sport; 3. Beta 2 agonists Lecture (2 hr)  
Tutorial 1 Tutorial (1 hr)  
Week 04 1. CNS stimulants; 2. Beta adrenergic blockers Lecture (2 hr)  
Week 05 1. Anabolic androgenic steroids; 2. Peptide hormones (growth hormone, EPO) Lecture (2 hr)  
Tutorial 2 Tutorial (1 hr)  
Week 07 1. Opioid analgesics; 2. NSAID analgesics Lecture (2 hr)  
Week 08 1. Diuretics; 2. Cardiovascular drugs Lecture (2 hr)  
Tutorial 3 Tutorial (1 hr)  
Week 10 1. Lipid lowering drugs; 2. Hypoglycaemics Lecture (2 hr)  
Tutorial 4 Tutorial (1 hr)  
Week 11 1. Asthma drugs; 2. Benzodiazepines; 3. Antidepressants; 4. Antipsychotics Lecture (2 hr)  
Tutorial 5 Tutorial (1 hr)  
Week 12 1. Immunology overview; 2. Innate immune system; 3. Adaptive immune system Lecture (2 hr)  
Tutorial 6 Tutorial (1 hr)  
Week 13 1. Immune function and acute exercise; 2. Immune function and chronic exercise Lecture (2 hr)  

Attendance and class requirements

Attendance: Content will be delivered in lecture and tutorial format as well as online activities.

Study commitment

Typically, there is a minimum expectation of 1.5-2 hours of student effort per week per credit point for units of study offered over a full semester. For a 6 credit point unit, this equates to roughly 120-150 hours of student effort in total.

Learning outcomes are what students know, understand and are able to do on completion of a unit of study. They are aligned with the University's graduate qualities and are assessed as part of the curriculum.

At the completion of this unit, you should be able to:

  • LO1. gain an understanding of basic actions and use of drugs in a sporting and therapeutic context
  • LO2. explain the action of a drug on body and body on a drug: understand the interaction of drug action with exercise, disease and ageing
  • LO3. understand how particular drugs are postulated to improve sporting performance
  • LO4. understand the drug testing procedure in elite athletes
  • LO5. understand the use of particular medications in therapeutic medications in the treatment of common diseases and disorders
  • LO6. understand the function of the immune system and immune responses
  • LO7. understand the interaction of the immune system with exercise, disease and ageing
  • LO8. communicate pharmacological and immunological knowledge in plain language English
  • LO9. search, critically evaluate, interpret and integrate information
  • LO10. provide evidence-based approach to clinical decision making
  • LO11. rationalise decision making
  • LO12. explain the underlying theory and principles guiding nutritional and pharmacological practice
  • LO13. communicate information clearly and appropriately in oral, written and graphical presentations
  • LO14. work in groups and contribute constructively to discussions
  • LO15. demonstrate ethically and professionally responsible behaviour.

Graduate qualities

The graduate qualities are the qualities and skills that all University of Sydney graduates must demonstrate on successful completion of an award course. As a future Sydney graduate, the set of qualities have been designed to equip you for the contemporary world.

GQ1 Depth of disciplinary expertise

Deep disciplinary expertise is the ability to integrate and rigorously apply knowledge, understanding and skills of a recognised discipline defined by scholarly activity, as well as familiarity with evolving practice of the discipline.

GQ2 Critical thinking and problem solving

Critical thinking and problem solving are the questioning of ideas, evidence and assumptions in order to propose and evaluate hypotheses or alternative arguments before formulating a conclusion or a solution to an identified problem.

GQ3 Oral and written communication

Effective communication, in both oral and written form, is the clear exchange of meaning in a manner that is appropriate to audience and context.

GQ4 Information and digital literacy

Information and digital literacy is the ability to locate, interpret, evaluate, manage, adapt, integrate, create and convey information using appropriate resources, tools and strategies.

GQ5 Inventiveness

Generating novel ideas and solutions.

GQ6 Cultural competence

Cultural Competence is the ability to actively, ethically, respectfully, and successfully engage across and between cultures. In the Australian context, this includes and celebrates Aboriginal and Torres Strait Islander cultures, knowledge systems, and a mature understanding of contemporary issues.

GQ7 Interdisciplinary effectiveness

Interdisciplinary effectiveness is the integration and synthesis of multiple viewpoints and practices, working effectively across disciplinary boundaries.

GQ8 Integrated professional, ethical, and personal identity

An integrated professional, ethical and personal identity is understanding the interaction between one’s personal and professional selves in an ethical context.

GQ9 Influence

Engaging others in a process, idea or vision.

Outcome map

Learning outcomes Graduate qualities
GQ1 GQ2 GQ3 GQ4 GQ5 GQ6 GQ7 GQ8 GQ9

Alignment with Competency standards

Outcomes Competency standards
LO1
Accredited Exercise Physiologist Professional Standards - ESSA
2.3.2. Distinguish common diagnostic procedures, medical, surgical and other interventions, and commonly prescribed medications for a broad range of target conditions across all AEP pathology domains.
3.3.2. Formulate comprehensive client histories that consider clinical risk and clinical safety factors and reasons for exercise.
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
7.3.2. Identify and describe the limitations, contraindications or considerationsthat may require the modification of assessments, and make appropriate adjustments for relevant populations or clients.
LO2
Accredited Exercise Physiologist Professional Standards - ESSA
2.3.2. Distinguish common diagnostic procedures, medical, surgical and other interventions, and commonly prescribed medications for a broad range of target conditions across all AEP pathology domains.
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
7.3.2. Identify and describe the limitations, contraindications or considerationsthat may require the modification of assessments, and make appropriate adjustments for relevant populations or clients.
LO3
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
LO5
Accredited Exercise Physiologist Professional Standards - ESSA
10.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks including hypo/hyperglycaemia and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
10.4.4. Recognise adverse clinical signs and symptoms including hypoglycaemic signs and symptoms; and identify and respond to changes in clinical status, co-morbidities, exercise and functional capacity, inter and intra session.
11.4.7. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, co-morbidities, indications, contraindications, exercise setting, treatment objectives and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise and intervention plans for individual musculoskeletal, rehabilitation and pre-employment clients.
12.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, acute and chronic exercise response in the design and delivery of safe and effective exercise for individual neurological clients.
13.4.5. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, treatment goals and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual respiratory/pulmonary clients.
2.3.2. Distinguish common diagnostic procedures, medical, surgical and other interventions, and commonly prescribed medications for a broad range of target conditions across all AEP pathology domains.
3.3.2. Formulate comprehensive client histories that consider clinical risk and clinical safety factors and reasons for exercise.
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
7.4.7. Consider medications, surgical and medical treatments/complications, allied health interventions/treatments, and clinical and safety risks and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual cardiovascular clients.
8.4.3. Consider medications; surgical, medical and allied health interventions/treatments including transplant and dialysis; clinical and safety risks and their implications on clinical status; and exercise and functional capacity in particular mobility in the design and delivery of safe and effective exercise for individual chronic kidney disease clients.
9.4.3. Consider medications, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
14.3.4. Understand the scope of practice for an exercise scientist, a sports scientist and an exercise physiologist.
4.3.4. Integrate knowledge of and skills in exercise prescription with other study areas of exercise science.
7.3.2. Identify and describe the limitations, contraindications or considerationsthat may require the modification of assessments, and make appropriate adjustments for relevant populations or clients.
LO7
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
LO8
Accredited Exercise Physiologist Professional Standards - ESSA
1.3.1. Illustrate the scope of practice of Accredited Exercise Physiologist (AEP) and the scope of roles available for AEP practice.
1.3.4. Employ evidence-based practice and professional clinical practice principles in the practice of the profession of an AEP.
3.3.2. Formulate comprehensive client histories that consider clinical risk and clinical safety factors and reasons for exercise.
Accredited Exercise Scientist Professional Standards - ESSA
15.3.2. Differentiate between high and lower quality sources of information to inform evidence-based practice.
15.3.3. Use the primary databases to access peer-reviewed scientific literature and conduct searches to identify relevant information.
15.3.5. Cite the research of others appropriately in written work.
LO9
Accredited Exercise Scientist Professional Standards - ESSA
15.3.2. Differentiate between high and lower quality sources of information to inform evidence-based practice.
15.3.3. Use the primary databases to access peer-reviewed scientific literature and conduct searches to identify relevant information.
15.3.4. Critically appraise research methodology and reports, including statistical results and ethical aspects of research, and integrate this knowledge into other study areas of exercise science.
15.3.5. Cite the research of others appropriately in written work.
Accredited Exercise Physiologist Professional Standards - ESSA
10.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks including hypo/hyperglycaemia and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
11.4.7. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, co-morbidities, indications, contraindications, exercise setting, treatment objectives and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise and intervention plans for individual musculoskeletal, rehabilitation and pre-employment clients.
12.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, acute and chronic exercise response in the design and delivery of safe and effective exercise for individual neurological clients.
13.4.5. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, treatment goals and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual respiratory/pulmonary clients.
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
7.4.7. Consider medications, surgical and medical treatments/complications, allied health interventions/treatments, and clinical and safety risks and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual cardiovascular clients.
8.4.3. Consider medications; surgical, medical and allied health interventions/treatments including transplant and dialysis; clinical and safety risks and their implications on clinical status; and exercise and functional capacity in particular mobility in the design and delivery of safe and effective exercise for individual chronic kidney disease clients.
9.4.3. Consider medications, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
Accredited Exercise Scientist Professional Standards - ESSA
15.3.2. Differentiate between high and lower quality sources of information to inform evidence-based practice.
15.3.3. Use the primary databases to access peer-reviewed scientific literature and conduct searches to identify relevant information.
15.3.4. Critically appraise research methodology and reports, including statistical results and ethical aspects of research, and integrate this knowledge into other study areas of exercise science.
Accredited Exercise Scientist Professional Standards - ESSA
14.3.4. Understand the scope of practice for an exercise scientist, a sports scientist and an exercise physiologist.
15.3.2. Differentiate between high and lower quality sources of information to inform evidence-based practice.
15.3.3. Use the primary databases to access peer-reviewed scientific literature and conduct searches to identify relevant information.
15.3.4. Critically appraise research methodology and reports, including statistical results and ethical aspects of research, and integrate this knowledge into other study areas of exercise science.
Accredited Exercise Physiologist Professional Standards - ESSA
10.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks including hypo/hyperglycaemia and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
10.4.4. Recognise adverse clinical signs and symptoms including hypoglycaemic signs and symptoms; and identify and respond to changes in clinical status, co-morbidities, exercise and functional capacity, inter and intra session.
11.4.7. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, co-morbidities, indications, contraindications, exercise setting, treatment objectives and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise and intervention plans for individual musculoskeletal, rehabilitation and pre-employment clients.
12.4.3. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, acute and chronic exercise response in the design and delivery of safe and effective exercise for individual neurological clients.
13.4.5. Consider medications, surgical, medical and allied health interventions/treatments, clinical and safety risks, treatment goals and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual respiratory/pulmonary clients.
2.3.2. Distinguish common diagnostic procedures, medical, surgical and other interventions, and commonly prescribed medications for a broad range of target conditions across all AEP pathology domains.
3.3.2. Formulate comprehensive client histories that consider clinical risk and clinical safety factors and reasons for exercise.
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
7.4.7. Consider medications, surgical and medical treatments/complications, allied health interventions/treatments, and clinical and safety risks and their implications on clinical status, exercise and functional capacity in the design and delivery of safe and effective exercise for individual cardiovascular clients.
8.4.3. Consider medications; surgical, medical and allied health interventions/treatments including transplant and dialysis; clinical and safety risks and their implications on clinical status; and exercise and functional capacity in particular mobility in the design and delivery of safe and effective exercise for individual chronic kidney disease clients.
9.4.3. Consider medications, medical and allied health interventions/treatments, clinical and safety risks and their implications on clinical status, exercise and functional capacity, and the design and delivery of safe and effective exercise for individual clients.
Accredited Exercise Scientist Professional Standards - ESSA
10.3.5. Integrate knowledge of and skills in human physiology with other study areas of exercise science.
14.3.3. Demonstrate effective verbal and nonverbal communication skills.
14.3.4. Understand the scope of practice for an exercise scientist, a sports scientist and an exercise physiologist.
7.3.2. Identify and describe the limitations, contraindications or considerationsthat may require the modification of assessments, and make appropriate adjustments for relevant populations or clients.
Accredited Exercise Physiologist Professional Standards - ESSA
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
Accredited Exercise Scientist Professional Standards - ESSA
14.3.3. Demonstrate effective verbal and nonverbal communication skills.
14.3.4. Understand the scope of practice for an exercise scientist, a sports scientist and an exercise physiologist.
Accredited Exercise Physiologist Professional Standards - ESSA
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
Accredited Exercise Scientist Professional Standards - ESSA
14.3.3. Demonstrate effective verbal and nonverbal communication skills.
Accredited Exercise Physiologist Professional Standards - ESSA
1.3.1. Illustrate the scope of practice of Accredited Exercise Physiologist (AEP) and the scope of roles available for AEP practice.
5.3.3. Relay medicines information including purpose and importance of compliance and exercise related side effects; and nutrition information aligned to nationally endorsed guidelines to clients considering clinical status and other influencing factors for client comprehension.
Accredited Exercise Scientist Professional Standards - ESSA
14.3.4. Understand the scope of practice for an exercise scientist, a sports scientist and an exercise physiologist.
14.3.5. Understand the elements of risk associated with the professional practice of exercise science and the strategies used to minimise this risk.
15.3.1. Describe the types and applications of qualitative and quantitative research study designs.

This section outlines changes made to this unit following staff and student reviews.

No changes have been made since this unit was last offered.

Disclaimer

The University reserves the right to amend units of study or no longer offer certain units, including where there are low enrolment numbers.

To help you understand common terms that we use at the University, we offer an online glossary.